RISK / BENEFIT ASSESSMENT OF DRUGS-ANALYSIS & RESPONSE RAD-AR Series No.44 2 3 5 8 9 10 11 12 14 15 16 19 20
RAD-AR News Vol.12, No.1 (May 2001) 2
3
RAD-AR News Vol.12, No.1 (May 2001) 4
5
RAD-AR News Vol.12, No.1 (May 2001) 6
7
RAD-AR News Vol.12, No.1 (May 2001) 8
9
RAD-AR News Vol.12, No.1 (May 2001) 10
11
Ito&Associates, Inc. RAD-AR News Vol.12, No.1 (May 2001) 12
13 Cancer Survivors Network Stevens Jonson Syndrome Foundation
RAD-AR News Vol.12, No.1 (May 2001) 14
15
RAD-AR News Vol.12, No.1 (May 2001) 16
17
RAD-AR News Vol.12, No.1 (May 2001) 18
19
RAD-AR News Vol.12, No.1 (May 2001) RISK / BENEFIT ASSESSMENT OF DRUGS-ANALYSIS & RESPONSE t s RADARRiskBenefit Assessment of Drugs-Analysis and Response RADARRADAR Council, Japan=RCJRADAR 19895 Pharmacoepidemiology RADAR RADAR News Volume 12, No.1Series No.44 2001 5 RADAR 1030001 42 23 5F Tel0336638891 Fax0336638895 http//wwwrad-arorjp/